CMS Open Payments · Program Year 2024
Echosens North America, Inc.
Echosens North America, Inc. reported $149,424.91 across General Payments, Research, and Ownership to 892 physicians and teaching hospitals across 892 transactions.
- $149.4K Below-median payer
- All-tracks total
- 892 Above-median volume
- Transactions
- 892 Above-median reach
- Recipients
- −$17.4K
- General Payments vs PY2023
Echosens North America, Inc. reported $149,424.91 across all CMS Open Payments tracks (General + Research + Ownership) to 892 physicians and teaching hospitals in Program Year 2024 - ranking #1083 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $149,424.91, averaging $167.52 per recipient.
How Echosens North America, Inc.'s $149.4K all-tracks total breaks down
Echosens North America, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
11/100
Transaction volume
F
16/100
Physician reach
F
17/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer echosens-north-america-inc Echosens North America, Inc.
$149.4K · #1083/1,925 · 0.0% industry · PY2024
- TOT $149.4K
- RANK #1083
- SHARE 0.0%
- TXN 892
- RCP 892
- CAT 4
- GEN $149.4K
- ΔGEN −$17.4K
- TOP1 20.6%
- PY 2024
Volume peers
Nearest volume peer: Cgg Medical Inc ($149.7K)
Echosens North America, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Echosens North America, Inc.'s CMS-reported General Payments decreased by $17.4K (−10.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ECHOSENS NORTH AMERICA, INC.PY2023: ECHOSENS NORTH AMERICA, INC.PY2024: Echosens North America, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $166,850.55
- PY2024
- $149,424.91
What the Data Shows for Echosens North America, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Echosens North America, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $70.7K, accounting for 47.3% of this company's General Payments and 57 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Echosens North America, Inc.'s 4-category general-payment breakdown at $70.7K, 47.3% of the reported total.
Echosens North America, Inc. reports 4 general-payment categories - the top three are Consulting Fee (47.3%), Compensation for Services Other Than Consulting (29.8%), and Food and Beverage (14.0%). The remaining 1 category make up 8.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Echosens North America, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $70.7K | 57 | 47.3% |
| Compensation for Services Other Than Consulting | $44.5K | 27 | 29.8% |
| Food and Beverage | $20.9K | 805 | 14.0% |
| Travel and Lodging | $13.2K | 3 | 8.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $99,939.67 (66.9%) of $149,424.91 in this company's General Payments records across 696 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Echosens North America, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Tejas Joshi
$30,707.83 across 25 reported transactions
- 2
Joel Brill
$28,365.67 across 11 reported transactions
- 3
Stephen Harrison
$20,000.00 across 4 reported transactions
- 4
Martin Grajower
$13,572.10 across 19 reported transactions
- 5
Raj Vuppalanchi
$7,294.07 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Echosens North America, Inc.'s spend rank (#1083 of 1,925, bottom 44% by spend) and concentration rank (#983 of 1,838, bottom 47% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Prismatik Dentalcraft, Inc. : $485.7K total payments, HHI 1132
- Gamida Cell Inc. : $31.5K total payments, HHI 1127
- Voom Medical Devices, Inc. : $76.9K total payments, HHI 1125
- Cryo Specialty Medical, LLC : $117.5K total payments, HHI 1121
- MeMed US, Inc. : $7.7K total payments, HHI 1121
- MiRus, LLC : $236.9K total payments, HHI 1119
- Echosens North America, Inc. (this company) : $149.4K total payments, HHI 1118
- Curium US LLC : $45.9K total payments, HHI 1118
- Noah Medical Corporation : $1.2M total payments, HHI 1114
- Life Technologies Corporation : $868.1K total payments, HHI 1114
- TearLab Corp : $77.8K total payments, HHI 1113
- American Regent : $64.2K total payments, HHI 1109
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Echosens North America, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Echosens North America, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Echosens North America, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Uromedica, Incorporated
One Lambda, Inc.
Benco Dental Supply Co.
Talis Clinical LLC
Asahi Intecc Co., Ltd.
Put this to use
Echosens North America, Inc. ranks #1083 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Echosens North America, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.